Studies in genetically modified animal models provide proofs of concept that this type of CaMKII-modified RyR behaviour can be a major arrhythmogenic factor that promotes HF and atrial fibrillation [31, 32]. The gene discussed is CAMK2G; the disease is atrial fibrillation.